TherapeuticsMD (TXMD) has shared an update.
TherapeuticsMD, Inc. recently disclosed its financial outcomes for the quarter ending June 30, 2024, through a press release. While this information is available for public view, it’s important to note that it has not been filed for regulatory purposes and should not be considered as part of the company’s official legal filings. The company also emphasizes that there is no commitment to publicly update any forward-looking statements that may have been made.
For a thorough assessment of TXMD stock, go to TipRanks’ Stock Analysis page.
